{'fraction_non_alphanumeric': 0.026865671641791045, 'fraction_numerical': 0.0, 'mean_word_length': 5.989583333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
QT Dispersion in HIV‐Infected Patients Receiving Combined Antiretroviral Therapy

A higher prevalence of QT prolongation has been reported among human immunodeficiency virus (HIV)‐infected patients. Previous studies have demonstrated that QT dispersion is a better predictor of serious ventricular tachyarrhythmia and cardiac mortality than corrected QT (QTc) interval. However, data of QT dispersion in HIV‐infected patients receiving a combined antiretroviral therapy (cART) is limited. We sought to assess QTc interval and QT dispersion in HIV‐infected patients receiving cART. The association between QT parameters and heart rate variability (HRV) was also examined.